Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Clearbridge Investments LLC

Clearbridge Investments LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,981,297 shares of the medical equipment provider’s stock after acquiring an additional 30,449 shares during the period. Intuitive Surgical accounts for about 0.7% of Clearbridge Investments LLC’s portfolio, making the stock its 29th largest holding. Clearbridge Investments LLC owned approximately 0.56% of Intuitive Surgical worth $881,380,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Creekmur Asset Management LLC lifted its stake in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical during the second quarter worth $26,000. Able Wealth Management LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $28,000. Delos Wealth Advisors LLC lifted its stake in Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares in the last quarter. Finally, LRI Investments LLC purchased a new stake in shares of Intuitive Surgical during the first quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,655,048.26. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 53,120 shares of company stock worth $25,528,753. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $491.27 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $496.18. The company has a market capitalization of $174.25 billion, a price-to-earnings ratio of 88.68, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. The firm has a 50-day simple moving average of $473.63 and a 200-day simple moving average of $429.56.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter in the prior year, the firm earned $1.18 earnings per share. The business’s quarterly revenue was up 14.5% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $475.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Citigroup upped their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Barclays upped their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Finally, BTIG Research increased their target price on Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $446.45.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.